U.S. federal trademark · Serial No. 86853847 · Reg. No. 5219355
Pharmaceutical preparations consisting primarily of amniotic cells for modulating immune system function, modulating tissue rejection, and repairing damaged tissues; Pharmaceutical preparations consisting primarily of cell growth medium conditioned by amniotic cells for modulating inflammation, repairing damaged tissues, and restoring tissue homeostasis; house mark for pharmaceutical preparations for modulating immune system function, modulating tissue rejection, repairing damaged tissues, modulating inflammation, and restoring tissue homeostasis
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.